Related Experiment Videos
Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report
Vincent Ho1, Maxwell Stewart, Peter Boyd
1School of Medicine, James Cook University, Cairns Base Hospital, Cairns, Queensland, Australia. vincent_ho@health.qld.gov.au
Journal of Medical Case Reports
|May 3, 2008
Summary
Cholestatic hepatitis, a rare side effect, may be caused by oxycodone. This case report highlights the potential for drug-induced liver injury, emphasizing physician awareness for prompt diagnosis and management.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Toxicology
Background:
- Oxycodone is a common semisynthetic opioid analgesic with established side effects.
- Cholestatic hepatitis has not been previously reported as a side effect of oxycodone.
Purpose of the Study:
- To report a case of cholestatic hepatitis potentially induced by oxycodone.
- To raise awareness among physicians about this rare adverse drug reaction.
Main Methods:
- A case presentation of a 34-year-old male with cholestatic jaundice and pruritus post-oxycodone use.
- Comprehensive laboratory and imaging studies were performed.
- Liver biopsy confirmed canalicular cholestasis suggestive of drug-induced hepatotoxicity.
Main Results:
- The patient presented with cholestatic jaundice and severe pruritus after oxycodone administration.
- Exclusion of other causes for jaundice was confirmed through extensive investigations.
- Resolution of symptoms and normalization of transaminases upon oxycodone withdrawal indicated drug causality.
Conclusions:
- Cholestatic hepatitis is a potential, albeit rare, side effect of oxycodone.
- Physicians should consider oxycodone-induced hepatotoxicity in patients presenting with cholestatic jaundice.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...